New Launch15 May 2026, 10:31 pm
Fredun Pharma Launches Hormone Range Products
AI Summary
Fredun Pharmaceuticals Ltd (BSE – FREDUN | 539730) has launched its “HORMONE RANGE PRODUCTS,” a premium specialty therapeutics brand focused on longevity, hormone health, recovery science, and human performance solutions. This initiative marks Fredun’s entry into the high-value healthcare segment driven by demand for preventive, performance-oriented therapeutics. The initial portfolio includes therapies based on testosterone, nandrolone, growth hormone-oriented solutions, and supportive hormone optimization therapies. The brand leverages Fredun's strengths in pharmaceutical formulation, manufacturing, and global distribution.
Key Highlights
- Fredun Pharma expands into longevity and specialty hormone therapeutics.
- The product range focuses on hormone optimization and preventive healthcare.
- The launch aims to strengthen Fredun’s innovation-led specialty pharma portfolio.
- The company will use a digital-led patient acquisition and retention strategy.
- The range includes therapies based on testosterone, nandrolone, and growth hormone solutions.